Rocket Pharmaceuticals and Inotek Pharmaceuticals Complete Merger Transaction03-Jan-2018
A recent article on Rocket Pharma merger and NASDAQ Listing –
Rocket Pharmaceuticals, Ltd., a leading U.S.-based multi-platform gene therapy company addressing challenging rare diseases, today announced the completion of its merger with Inotek Pharmaceuticals Corporation
Read the full article
Rocket utilizes a multi-platform development approach that leverages the well-established lentiviralvector (LVV) and adeno-associated viral vector (AAV) gene delivery methods and is initially targeting devastating rare diseases in children that lead to early mortality in the absence of bone marrow transplant or other invasive procedures.